CTI is developing medicines to help treat your cancer while maintaining your quality of life.
Pixantrone is marketed by CTI in the EU as Pixuvri®.Summary of Product Characteristics and Package Insert
Learn about our potential treatments for non-Hodgkin Lymphoma.See Phase 3 Pipeline
Learn about our potential treatments for Acute Myeloid Leukemia (AML), Myelodysplasia (MDS).See Phase 1 Pipeline
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014
Cell Therapeutics to Present at the 26th Annual ROTH Conference
BAXTER AND CELL THERAPEUTICS ANNOUNCE WORLDWIDE STRATEGIC COLLABORATION TO DEVELOP AND COMMERCIALIZE PACRITINIBLearn more
Our late-stage development pipeline addresses a full complement of blood-related cancers.learn about our oncology pipeline